104 Impact is an advisory firm collaborating with visionary founders of companies dedicated to addressing global challenges. Our objective revolves around forging enduring partnerships with these founders, with a commitment to partnering with companies through long-term initiatives that culminate in creating a positive impact and a successful exit.

Peptilogics, is a company at the forefront of revolutionizing the treatment of periprosthetic joint infection and leveraging a powerful AI discovery platform, Nautilus. Peptilogics has been at the forefront of developing revolutionary peptide-based therapies that tackle infectious diseases and other serious medical conditions. The company's innovative approach to harnesses the potential of peptides, leads highly effective and safe treatments for patients. The rise of antibiotic-resistant… Show more Peptilogics, is a company at the forefront of revolutionizing the treatment of periprosthetic joint infection and leveraging a powerful AI discovery platform, Nautilus. Peptilogics has been at the forefront of developing revolutionary peptide-based therapies that tackle infectious diseases and other serious medical conditions. The company's innovative approach to harnesses the potential of peptides, leads highly effective and safe treatments for patients. The rise of antibiotic-resistant bacteria is one of the most pressing global health challenges. Peptilogics' groundbreaking peptide therapies offer a viable solution, helping combat these infections and safeguarding public health. We are currently backed by Peter Thiel, Founders Fund, PreSight Capital, Alpha Wave Global, Point72 Ventures, and CARB-X and are currently raising our 75MM Series C round. Show less